Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-12

Clinical Trial Update: Intravenous Voriconazole in Patients With Renal Compromise

View source ↗

Summary

A completed clinical trial evaluating intravenous voriconazole in patients with renal impairment, including those with renal transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vfend (voriconazole) (voriconazole)

Snippet

Sponsor: University of Pittsburgh | Conditions: Renal Transplant | Status: COMPLETED